The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, producing billions in revenue , its exclusivity period created a wave of lower-priced alternatives , significantly diminishing its position . While specific businesses may attempt to capitalize on similar conditions , the